Obesity
Showing NaN - NaN of 54
Spinal Cord Injuries, Obesity, Cardiometabolic Syndrome Trial in United States (PVA Consumer Guide, WebMD)
Not yet recruiting
- Spinal Cord Injuries
- +2 more
- PVA Consumer Guide
- WebMD
-
Washington, District of Columbia
- +4 more
Aug 16, 2023
Obesity Trial in United States (Semaglutide 2.4 mg and NNC0165-1875 2.0 mg, Semaglutide 2.4 mg and 2.0 mg, Semaglutide 2.4 mg
Completed
- Obesity
- Semaglutide 2.4 mg and NNC0165-1875 2.0 mg
- +3 more
-
Walnut Creek, California
- +13 more
Jan 23, 2023
Overweight, Obesity and Diabetes, Type 2 Trial (Cagrilintide, Semaglutide, Placebo cagrilintide)
Not yet recruiting
- Overweight
- +2 more
- Cagrilintide
- +3 more
-
Concord, California
- +147 more
Jan 24, 2023
Obesity, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo)
Recruiting
- Obesity
- Diabetes Mellitus, Type 2
- Semaglutide
- Placebo
-
Birmingham, Alabama
- +73 more
Jan 24, 2023
Overweight, Obesity Trial in Worldwide (Semaglutide, Placebo (semaglutide))
Active, not recruiting
- Overweight
- Obesity
- Semaglutide
- Placebo (semaglutide)
-
Birmingham, Alabama
- +804 more
Dec 19, 2022
Obesity, Heart Failure With Normal Ejection Fraction Trial in Richmond (UFA dietary recommendations)
Active, not recruiting
- Obesity
- Heart Failure With Normal Ejection Fraction
- UFA dietary recommendations
-
Richmond, VirginiaVirginia Commonwealth University
Nov 17, 2022
Obesity Trial in Richmond (Wellness Engagement Intervention)
Recruiting
- Obesity
- Wellness Engagement Intervention
-
Richmond, VirginiaVirginia Commonwealth University
Sep 13, 2022
Overweight, Obesity Trial in Worldwide (Gelesis100, )
Completed
- Overweight
- Obesity
- Gelesis100
- placebo
-
Anaheim, California
- +35 more
Aug 8, 2022
Non-Alcoholic Fatty Liver Disease, Fatty Liver, Nonalcoholic, Obesity Trial in Richmond (Mindfulness Based Stress Reduction
Recruiting
- Non-Alcoholic Fatty Liver Disease
- +2 more
- Mindfulness Based Stress Reduction (MBSR)
-
Richmond, VirginiaVirginia Commonwealth University
Jul 22, 2022
Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (Semaglutide, Placebo)
Completed
- Metabolism and Nutrition Disorder
- Obesity
- Semaglutide
- Placebo
-
Anniston, Alabama
- +71 more
Jan 7, 2022
Weight Loss, Men, Lifestyle Risk Reduction Trial in Richmond (Self-guided lifestyle intervention)
Completed
- Weight Loss
- +4 more
- Self-guided lifestyle intervention
-
Richmond, VirginiaVirginia Commonwealth University School of Medicine
Jul 19, 2021
Obesity Trial in United States (lorcaserin HCl XR, Placebo)
Terminated
- Obesity
- lorcaserin hydrochloride XR
- Placebo
-
Phoenix, Arizona
- +15 more
Jun 29, 2021
Obesity, High Blood Pressure, High Cholesterol Trial in Richmond (Curcumin)
Completed
- Obesity
- +4 more
- Curcumin
-
Richmond, VirginiaVirginia Commonwealth University
Jan 25, 2021
Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (semaglutide, liraglutide, )
Completed
- Metabolism and Nutrition Disorder
- Obesity
- semaglutide
- +2 more
-
Anaheim, California
- +73 more
Apr 14, 2020
Liver and Cardiometabolic Health Benefits on Low Carbohydrate
Completed
- Obesity
- +2 more
- Fibroscan changes with different diets
-
Richmond, VirginiaVirginia Commonwealth University
Mar 9, 2020
Obesity Trial in Richmond (Behavioral Weight Loss (BWL), BWL + Autonomous Motivation, BWL + Extrinsic Motivation)
Completed
- Obesity
- Behavioral Weight Loss (BWL)
- +2 more
-
Richmond, VirginiaVirginia Commonwealth University, School of Medicine
Feb 10, 2020
Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)
Completed
- Cardiovascular Disease
- +4 more
- Lorcaserin hydrochloride
- Placebo
-
Alexander City, Alabama
- +498 more
Jun 27, 2019
Heart Failure With Normal Ejection Fraction, Obesity Trial in Richmond (Increasing daily unsaturated fatty acid consumption)
Completed
- Heart Failure With Normal Ejection Fraction
- Obesity
- Increasing daily unsaturated fatty acid consumption
-
Richmond, VirginiaVirginia Commonwealth University
Apr 16, 2019
Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Fatigue Trial in Korea, Republic of, United States
Unknown status
- Endometrial Clear Cell Adenocarcinoma
- +6 more
- 3-Dimensional Conformal Radiation Therapy
- +7 more
-
Birmingham, Alabama
- +539 more
Mar 8, 2019